Latest News about ABBV
Recent news which mentions ABBV
3 High-Yield Dividend Stocks I'm Not Selling Anytime Soon
October 18, 2021
From Motley Fool
3 Best Dividend Stocks for Retirement
October 16, 2021
From Motley Fool
2 Buffett Stocks to Buy and Hold Forever
October 16, 2021
From Motley Fool
Want More Monthly Income? Invest in These 3 Stocks
October 15, 2021
From Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
From Benzinga
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program
October 11, 2021
From Benzinga
From Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
October 08, 2021
From Benzinga
Former Tilray CEO Joins Psychedelics Company
October 07, 2021
From Benzinga
AbbVie Touts Additional Rinvoq Data In Inflammatory Spinal Arthritis
October 07, 2021
Tickers
ABBV
From Benzinga
Why AbbVie Stock Sank in September
October 07, 2021
From Motley Fool
Investing in Pharma Stocks? Watch for These 2 Red Flags
October 04, 2021
From Motley Fool
Johnson & Johnson Sell-Off: Is It a Buying Opportunity?
October 03, 2021
From Motley Fool
Here's What Warren Buffett Looks For With Healthcare Stocks
October 02, 2021
From Motley Fool
AbbVie Presents New Upadacitinib Data In Atopic Dermatitis
September 30, 2021
Tickers
ABBV
From Benzinga
AbbVie Unveils New Durable Risankizumab Data In Psoriatic Arthritis
September 30, 2021
Tickers
ABBV
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
I-Mab In Talks With Pharma Giants About Partnership, Stake Sale: Bloomberg
September 29, 2021
From Benzinga
Here's How a New Investor Started Her Portfolio With Just 10 Top Stocks
September 29, 2021
From Motley Fool
FDA Gives Nod To First Oral CGRP Receptor To Prevent Migraine From AbbVie
September 29, 2021
Tickers
ABBV
From Benzinga
Here's Why Investors Shouldn't Count Out Johnson & Johnson as a Coronavirus Vaccine Stock
September 29, 2021
From Motley Fool
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
Here's Why AbbVie Is a Great Healthcare Stock for Long-Term Investors
September 29, 2021
From Motley Fool
7 Biotech Stocks Entering the Golden Boom Phase
September 28, 2021
From InvestorPlace
3 Top Stocks for Retirees
September 28, 2021
From Motley Fool
Could AbbVie's New Collaboration Be a Blockbuster?
September 27, 2021
From Motley Fool
3 High-Yield Dividend Stocks Warren Buffett Loves
September 27, 2021
From Motley Fool
3 Top Biotech Stocks to Buy for the Long Haul
September 27, 2021
From Motley Fool
Barron's Latest Picks And Pans: Healthcare Roundtable Picks, Dividend Aristocrats And More
September 25, 2021
From Benzinga
Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal
September 25, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.